PRP guidelines · International

Platelet-rich plasma shows beneficial effects for patients with knee osteoarthritis by suppressing inflammatory factors

Guilin Huang, Sha Hua, Tuanmin Yang, Jianbing Ma, Wenxing Yu, Xiujin Chen

Experimental and Therapeutic Medicine · 2018

In brief

This clinical study randomised young adults with knee osteoarthritis to weekly platelet-rich plasma (PRP) or placebo injections and measured blood markers of inflammation and blood-vessel growth. The authors report that PRP reduced these markers and joint inflammation compared with placebo, and suggest PRP may be a potential treatment, though some side effects were recorded.

Read the original paper (opens in a new tab)

Citation, as listed in the PRP guidelines

Platelet-rich plasma shows beneficial effects for patients with knee osteoarthritis by suppressing inflammatory factors Authors: Guilin Huang, Sha Hua, Tuanmin Yang, Jianbing Ma, Wenxing Yu, Xiujin Chen Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC5867452/ Year of Publication: 2018

A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.

More from the PRP guidelines

Ready to rewrite your health story?

Request a callback from our team.